Somerset Therapeutics LLC recalls Cisatracurium Besylate Injection USP
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Subpotent product:out of specification assay results observed during long term stability testing.
- Products
-
- Cisatracurium Besylate Injection USP
- Company
- Somerset Therapeutics LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 28,660 20mL vials
- About this recall
- Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10.